This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n23http://linked.opendata.cz/resource/drugbank/drug/DB01430/identifier/chebi/
n13http://linked.opendata.cz/resource/mesh/concept/
n7http://linked.opendata.cz/resource/drugbank/company/
n9http://linked.opendata.cz/resource/drugbank/drug/DB01430/identifier/wikipedia/
n8http://linked.opendata.cz/resource/drugbank/drug/DB01430/identifier/pharmgkb/
n17http://bio2rdf.org/drugbank:
n18http://linked.opendata.cz/resource/drugbank/drug/DB01430/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n20http://linked.opendata.cz/resource/drugbank/drug/DB01430/identifier/pubchem-substance/
n22http://linked.opendata.cz/resource/drugbank/drug/DB01430/identifier/kegg-drug/
n19http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n21http://linked.opendata.cz/resource/drugbank/drug/DB01430/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n15http://linked.opendata.cz/resource/drugbank/medicinal-product/
n12http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/ontology/sukl/drug/
n11http://linked.opendata.cz/resource/atc/
n4http://linked.opendata.cz/resource/drugbank/drug/DB01430/identifier/chemspider/

Statements

Subject Item
n2:DB01430
rdf:type
n5:Drug
n5:description
A respiratory stimulant that enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease. It may also prove useful in the treatment of nocturnal oxygen desaturation without impairing the quality of sleep. [PubChem]
n5:group
approved
n5:indication
For the treatment of chronic obstructive pulmonary disease.
owl:sameAs
n17:DB01430 n19:DB01430
dcterms:title
Almitrine
adms:identifier
n4:31235 n8:PA164750492 n9:Almitrine n18:33887 n20:46505517 n21:DB01430 n22:D02822 n23:53778
n5:mechanismOfAction
Almitrine enhances respiration by acting as an agonist of peripheral chemoreceptors located on the carotid bodies. The drug increases arterial oxygen tension while decreasing arterial carbon dioxide tension in patients with chronic obstructive pulmonary disease.
n5:packager
n7:271B49FF-363D-11E5-9242-09173F13E4C5
n5:synonym
2,4-Bis(allylamino)-6-(4-(bis(P-fluorophenyl)methyl)-1-piperazinyl)-S-triazine Almitrinum Almitrina
n5:salt
n12:hasConcept
n13:M0024158
n5:IUPAC-Name
n6:271B4A05-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B4A0B-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B4A0A-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B4A07-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B4A08-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B4A09-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B4A03-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B4A04-363D-11E5-9242-09173F13E4C5 n6:271B4A01-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B4A02-363D-11E5-9242-09173F13E4C5
n10:hasATCCode
n11:R07AB07
n5:H-Bond-Acceptor-Count
n6:271B4A11-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B4A12-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B4A0C-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B4A0D-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B4A0F-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B4A0E-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B4A10-363D-11E5-9242-09173F13E4C5
n5:affectedOrganism
Humans and other mammals
n5:casRegistryNumber
27469-53-0
n5:category
n5:containedIn
n15:271B4A00-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B4A17-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B4A19-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B4A1A-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B4A16-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B4A15-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B4A18-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B4A06-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B4A13-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B4A14-363D-11E5-9242-09173F13E4C5